Biotechnology

SPT Labtech, a global player in the design and development of automated instrumentation and consumables for life science applications, has acquired BioMicroLab, a robotics automation provider for life science laboratories. Headquartered in Northern California, BioMicroLab designs and manufactures laboratory automation equipment for biotechnology and scientific research. BioMicroLab’s extensive range of sample handling and tracking solutions […]

ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio. ERS Genomics was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier. ZeClinics is a contract research organisation using zebrafish to carry out services focused on analysing the safety, […]

The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7 in Great Britain and other countries shows changes in the genome of the SARS-CoV-2 virus can lead to new biological properties. Most of the approximately 12,000 mutations in the genome of the SARS-CoV-2 virus that have been identified since February 2020 so far did […]

Lu Rahman looks at the role of the biotech sector in the development of new therapeutics and why this industry is a vital element in drug discovery For reasons we would clearly have preferred not to happen, the global spotlight has  – understandably – been on the biotech sector since early 2020. Throughout the pandemic, […]

Sam Cooper founded Phenomic AI in 2017 alongside Oren Kraus, as an early stage biotech company seeking to commercialise AI approaches for pharmaceutical R&D. He discusses the role of AI in drug discovery with Lu Rahman. LR: Where are we with deep learning and drug discovery and how effective is it for researchers? How well […]

Purification specialists Reach Separations and French drug discovery CRO, NovAliX, have entered into an alliance to develop supercritical fluid chromatography (SFC) capabilities at the NovAliX facility near Strasbourg. Formed in support of Reach Separations’ strategy to grow its European presence, and in response to a sustained rise in demand for purification expertise from NovAliX’s clients, […]

Leukocare, a German biotechnology company specialising in formulation development for biologics, viral vectors and vaccines, has opened development labs in Milford, USA. Its headquarters will remain in Martinsried/Munich, Germany. Being present in the US market offers the opportunity to collaborate closely with customers and partners on tailor-made solutions in the field of drug product formulation […]

This article is the first in a two-part series based on The Pistoia Alliance report. Written in retrospect from the world as it is in 2030, it looks at how healthcare has changed in the intervening decade, covering the socio-economic and political evolutions that have happened, the subsequent effects on population health and the innovative […]

Hummingbird Bioscience, a clinical-stage biotech company focused on developing revolutionary therapies for hard-to-drug targets, is collaborating with Tempus, an expert in artificial intelligence and precision medicine. This will drive the development of Hummingbird’s lead clinical program, HMBD-001, as it advances into clinical trials in HER3-driven cancers, including those that harbour neuregulin 1 (NRG1) fusions. As […]

Global mammalian transient protein market revenues are projected to surpass US$ 540 million in 2020, according to a new study by Future Market Insights. The report also states that, innovations in automation and recombinant proteins will support market developments, however, prohibitive costs and complexity to maintain media purity remain challenges. Key takeaways on mammalian transient […]

The Jefferies Healthcare Temperature Check report is now in its third edition and published to coincide with the 11th annual Global Healthcare Conference which was held virtually. Over 500 responses from senior leaders in the sector responded for this year’s report, giving views on both the current state of the market and predictions for 2021. […]

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions (Sterling), has announced a new strategic partnership with ADC Biotechnology (ADC Bio), a UK based biotechnology company specialising in antibody drug conjugates. The partnership will see Sterling make a significant investment in the business with a view to acquiring ADC Biotechnology in Q1 next year, […]

Oxeia Biopharmaceuticals is a clinical stage biotech company developing a drug treatment for concussion to address underlying neuro-metabolic dysfunction and axonal injury. It has announced the initiation of a Phase II clinical trial of OXE103 for treating concussion. The Phase II clinical study is being conducted by Dr. Michael Rippee, Assistant Professor of Neurology at […]

Since 2017 we have seen the slow and steady adoption of User Experience (UX) within the life sciences. User Experience is an evidence-based design process that centres on the behaviours and needs of users. The clear benefits of UX offered in the retail and consumer sectors have been slow to percolate to other more complex […]

STORM Therapeutics will use INDiGO, Evotec’s integrated, accelerated IND-enabling platform, to progress its STC-15 towards an IND application in 2021. STORM, a biotechnology company focused on the discovery and development of small molecule therapies modulating RNA epigenetics, has selected STC-15 as a first-in-class development candidate. STORM discovered STC-15, an orally bioavailable, small molecule inhibitor of […]

Evotec is expanding its campus in Abingdon, Oxfordshire, UK, into a major, fully-integrated, co-located discovery and development centre to be named Dorothy Crowfoot Hodgkin Campus. Adding a new building, which will house up to 100 biologists by the end of the year, will bring together all the key functions for  high-performance small molecule discovery up […]